Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Xiaoyan Lin | Researchclopedia

Back to researchers

Xiaoyan Lin

Fujian Medical University ORCID

152

Works

6,048

Citations

24

h-index

44

i10-index

Research Topics

Gastric Cancer Management and Outcomes Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations

Affiliations

Qingdao University2013–2013

Tongji University2019–2020

Fujian Medical University2006–2025

Army Medical University2025–2025

Shandong University2013–2023

Top Works

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

Jin Li,Shukui Qin,et al.

2016986 citations

Colorectal Cancer Treatments and Studies

Gastrointestinal Tumor Research and Treatment

Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial

Shukui Qin,Zhenggang Ren,et al.

2020632 citations

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

Shukui Qin,Stephen L. Chan,et al.

2023619 citations

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

Caicun Zhou,Gongyan Chen,et al.

2020493 citations

Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

Hai-Qiang Mai,Qiu-Yan Chen,et al.

2021392 citations

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

Feng‐Hua Wang,Xiaoli Wei,et al.

2021342 citations

Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma

Hai‐Qiang Mai,Qiuyan Chen,et al.

2023210 citations

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

Xiangyu Gao,Nong Xu,et al.

2023180 citations

Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial

Yun Fan,Jun Zhao,et al.

2020138 citations